ABBOTT PANBIO Nasopharyngeal Tests
A rapid in vitro diagnostic test for the qualitative detection of SARS-CoV-2 antigen (Ag) in
human nasopharyngeal swab samples from people who meet the clinical and/or epidemiological criteria for COVID-19.
The Panbio™ COVID-19 Ag Rapid Test Device is for professional use only and is intended to be used as an aid in diagnosis
of SARS-CoV-2 infection. The product can be used in any environment both in the laboratory and outside the laboratory.
laboratory, provided that it meets the requirements specified in the Instructions for Use and local regulations.
The test provides preliminary analysis results. Negative results do not rule out SARS-CoV-2 infection and
They cannot be used as the sole basis for treatment or other management decisions.
Negative results should
be combined with clinical observations, patient history and epidemiological information. The test is not designed to be used
as a donor screening test for SARS-CoV-2.
ABBOTT PANBIO Nasopharyngeal Tests (Box with 25 Tests) COVID-19
For patients with suspected current COVID-19 infection.
Quick answers for patients: test results.
in 15–20 minutes
Reliable, high performance*
Sensitivity: 93,3% (98,2% for samples with Ct values ≤33)
Specificity: 99,4%
To implement at the point of care in a variety of
scenarios.
The affordable solution allows for large-scale testing.
DOCUMENTATION:
https://www.prosaludmexico.com/wp-content/uploads/2022/01/Pruebas-ABBOTT-PANBIO-Nasofaringeas-Caja-con-25-Pruebas-COVID-19-2.pdf
Visit our social networks:
Ratings
There are no reviews yet